| 刊名 | Medicinal Plant |
| 作者 | Hanrui BAI, Chunhui LIU, Yanbin LI, Lifen WANG, Zeyu WU, Qin WANG, Wenling CONG, Jiawei LIU |
| 作者单位 | College of Traditional Chinese Medicine, Inner Mongolia Medical University, Jinshan Economic and Technological Development Zone |
| DOI | DOI:10.19600/j.cnki.issn2152-3924.2026.05.013 |
| 年份 | 2026 |
| 刊期 | 5 |
| 页码 | 73-77 |
| 关键词 | Cerebral ischemia-reperfusion injury (CIRI), Qizhi Formula, Microglial polarization, Wnt/β-catenin signaling pathway, Neuroinflammation |
| 摘要 | [Objectives] To investigate the cerebroprotective mechanisms of Qizhi Formula against cerebral ischemia-reperfusion injury (CIRI) through in vitro cellular experiments. [Methods] The injury model of BV2 microglia induced by oxygen-glucose deprivation/reoxygenation (OGD/R) was established. The reliability of the model was validated through cell counting kit-8 (CCK-8) and lactate dehydrogenase (LDH) release assays. Successfully modeled BV2 cells were subsequently allocated into six groups: blank, model, nimodipine, Astragali Radix, Hirudo, and Qizhi Formula groups, with corresponding drug-containing sera prepared for each. Enzyme-linked immunosorbent assay (ELISA) was employed to quantify the levels of pro-inflammatory cytokines (TNF-α, IL-1β) and anti-inflammatory cytokines (IL-10, TGF-β) in the cell culture supernatants. Real-time quantitative polymerase chain reaction (RT-qPCR) was conducted to assess the mRNA expression of M1 microglial markers (CD86, iNOS) and M2 microglial markers (CD206, Arg1) across the different groups. [Results] ELISA results showed that, compared to the blank control group, the model group exhibited a significant increase in pro-inflammatory factor levels alongside a decrease in anti-inflammatory factors. In comparison to the model group, treatment with drug-containing serum from all drug intervention groups significantly downregulated the expression of TNF-α and IL-1β, while upregulating IL-10 and TGF-β levels in OGD/R-injured BV2 cells (P<0.01). Furthermore, Qizhi Formula produced superior effects relative to single treatments with Astragali Radix or Hirudo (P<0.05). RT-qPCR analysis revealed that OGD/R stimulation significantly increased the mRNA expression of M1 markers CD86 and iNOS in BV2 cells. Treatment with nimodipine and Qizhi Formula markedly inhibited the upregulation of these M1 markers (P<0.01) while concurrently enhancing the mRNA expression of M2 markers CD206 and Arg1 (P<0.01). [Conclusions] Qizhi Formula provides cerebroprotection against CIRI by regulating the M1/M2 polarization balance of BV2 microglia and attenuating excessive neuroinflammatory responses, thereby offering pharmacological evidence supporting the use of this formula. |